Related Experiment Video

Updated: Aug 11, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection

Yee-Joo Tan1, Seng Gee Lim, Wanjin Hong

  • 1Collaborative Anti-Viral Research group, Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673. mcbtanyj@imcb.a-star.edu.sg

Current HIV Research
|February 4, 2006
PubMed

Insights

Coinfection with human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) complicates treatment and alters disease progression. Understanding viral interactions is key to developing effective HIV/HCV therapies.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Coinfection with HIV-1 and HCV is increasing.
  • HIV-1/HCV coinfection complicates antiretroviral therapy.
  • Viral interactions affect treatment efficacy and disease progression.

Purpose of the Study:

  • To review scientific investigations on HIV/HCV coinfection.
  • To summarize knowledge on immune evasion, viral evolution, and protein interactions.
  • To highlight the importance of understanding viral interplay for therapeutic development.

Main Methods:

  • Literature review of scientific investigations.
  • Classification of studies into immune evasion, viral evolution, and protein-host interactions.
  • Synthesis of cumulative knowledge in the field.

Main Results:

  • HIV-1/HCV coinfection presents complex challenges in treatment and disease management.
  • Bidirectional viral interferences significantly impact the natural history of both infections.
  • Research highlights mechanisms of immune evasion and viral diversity in coinfection.

Conclusions:

  • Understanding the complex interplay between HIV-1 and HCV is crucial.
  • Further research into viral protein functions and host interactions is needed.
  • This knowledge will guide the development of improved antiviral therapeutics for coinfected patients.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...